Celldex Therapeutics Inc (CLDX)

Celldex Financial Statements


Celldex Financial Overview

Celldex's market cap is currently ―. The company's EPS TTM is $-2.144; its P/E ratio is -13.42; Celldex is scheduled to report earnings on November 8, 2022, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 163.00K$ 174.00K$ 334.00K$ 153.00K$ 3.48M
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -27.72M$ -23.79M$ -20.59M$ -19.23M$ -13.18M
EBITDA$ -26.98M$ -22.98M$ -19.81M$ -18.47M$ -12.42M
Net Income Common Stockholders$ -36.00M$ -23.05M$ -20.15M$ -20.45M$ -13.37M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 164.04M$ 176.08M$ 194.42M$ 199.59M$ 356.82M
Total Assets$ 402.96M$ 424.04M$ 444.65M$ 460.20M$ 204.55M
Total Debt$ 2.10M$ 2.62M$ 2.78M$ 3.08M$ 3.14M
Net Debt$ -161.93M$ -173.46M$ -191.65M$ -196.51M$ -353.68M
Total Liabilities$ 37.87M$ 25.94M$ 25.18M$ 23.49M$ 22.27M
Stockholders Equity$ 182.28M$ 194.17M$ 209.36M$ 229.97M$ 365.09M
Cash Flow
Free Cash Flow$ -22.92M$ -25.11M$ -14.88M$ -16.56M$ -12.07M
Operating Cash Flow$ -22.24M$ -24.53M$ -14.52M$ -16.37M$ -11.93M
Investing Cash Flow$ 25.28M$ 10.38M$ -18.94M$ -226.79M$ -13.91M
Financing Cash Flow$ 71.00K$ 304.00K$ 426.00K$ 271.90M$ -25.00K
Currency in USD

Celldex Earnings and Revenue History

Celldex Debt to Assets

Celldex Cash Flow

Celldex Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis